Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe site revision identifier changed from v3.8.0 to v3.8.1; the study record content remains unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedThe clinical trial record for RRADICAL is now displayed, with study design, participant criteria, treatment details, outcome measures, and record dates. The page also includes study documents and notes that no Statistical Analysis Plan exists.SummaryDifference50%

- Check17 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 while the study page displays a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA site-wide NIH announcement about website changes appears above the ClinicalTrials.gov 403 error page. The site revision also advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check45 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page components related to study documents and metadata (including the SAP note and several document entries) have been removed, reducing the amount of visible procedural and documentation information on the study record.SummaryDifference18%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.